Your browser doesn't support javascript.
loading
Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatment.
Dawson, John C; Munro, Alison; Macleod, Kenneth; Muir, Morwenna; Timpson, Paul; Williams, Robert J; Frame, Margaret; Brunton, Valerie G; Carragher, Neil O.
Affiliation
  • Dawson JC; Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Munro A; Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Macleod K; Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Muir M; Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Timpson P; Cancer Theme, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia.
  • Williams RJ; Cancer Research UK Centre for Drug Development, London, UK.
  • Frame M; Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Brunton VG; Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Carragher NO; Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
Mol Oncol ; 16(5): 1072-1090, 2022 03.
Article in En | MEDLINE | ID: mdl-34856074

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinazolines / Neoplasms Limits: Animals / Humans Language: En Journal: Mol Oncol Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinazolines / Neoplasms Limits: Animals / Humans Language: En Journal: Mol Oncol Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Reino Unido